Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 07, 2015 6:39 PM ET

Biotechnology

Company Overview of ZIOPHARM Oncology, Inc.

Executive Profile

Jedd D. Wolchok M.D., Ph.D.

Member of Scientific Advisory Board, ZIOPHARM Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Jedd D. Wolchok, M.D. Ph.D. serves as a Co-Editor at Cytokines, Cellular and Molecular Therapy. Dr. Wolchok serves as an associate director and director of immunotherapy clinical trials for the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center. He serves as Member of Clinical Advisory Board and Member of Scientific Advisory Board - Melanoma of Altor BioScience Corporation. He serves as Associate Director of the Scientific Advisory Council ...

Corporate Headquarters

Parris Building 34
Boston, Massachusetts 02129

United States

Phone: 617-259-1970
Fax: 617-241-2855

Board Members Memberships

Director

Education

PhD
New York University
MD
NYU Elaine A. and Kenneth G. Langone Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$861.1K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$543.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIOPHARM Oncology, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.